Trial · NCT07903571
Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young
NCT07903571, Not yet recruiting, Royal Marsden NHS Foundation Trust
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young. Trials, record NCT07903571. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903571
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young
- NCT number
- NCT07903571
- Status
- Not yet recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Conditions
- Colorectal Cancer, Gastro-oesophageal Adenocarcinoma, Hepato-Biliary Carcinoma in Situ Nos
- Interventions
- Research blood samples
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Establishment of a prospective early-onset gastrointestinal cancer cohort and biorepositor | 5 years | Number of participants recruited to the cohort with linked biospecimen collection, clinical data capture, and longitudinal follow-up completed according to protocol. |
| Secondary | Lifestyle, dietary, environmental, and early-life exposures | Baseline and up to 5 years follow-up | Characterisation of lifestyle, dietary, environmental, and early-life factors and their association with cancer subtype, molecular characteristics, disease stage, and clinical outcomes. |
| Secondary | Gut microbiome characteristics | Baseline and up to 5 years follow-up | Association between gut microbiome composition and tumour characteristics, treatment response, disease progression, and survival outcomes. |
| Secondary | Circulating biomarkers and translational research markers | Baseline and up to 5 years follow-up | Changes in patient-reported quality of life following diagnosis and treatment of early-onset gastrointestinal cancer, as measured using validated questionnaires. |
| Other | Development of patient-derived in vivo models | up to 5 years. | Proportion of collected tumour samples successfully used to establish and characterise patient-derived animal models. |
| Other | Development of patient-derived organoid models | up to 5 years | Proportion of collected tumour samples successfully used to establish and characterise patient-derived organoid models for translational research studies. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903571
GET https://conductscience.org/api/trials/v1/NCT07903571/registered